Pharmacyte BiotechPMCB
13F holders, Q1 2024 (March 31)4holders
$2.28avg. 13F price*
At the end of Q1 2024, 4 institutions reported holding Pharmacyte Biotech Inc. (PMCB) in their 13F filings. The largest holders were Anchor Investment Management, LLC ($64), Caldwell Sutter Capital, Inc. ($5) and Carolina Wealth Advisors, LLC ($4).
- Company
- Pharmacyte Biotech Inc.
- CUSIP
- 71715X104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
No earlier quarter to compare with.
Ownership 4 holders
| Anchor Investment Management, LLC | 0.00% | No change | 27 | $64 |
| Caldwell Sutter Capital, Inc. | 0.00% | No change | 2 | $5 |
| Carolina Wealth Advisors, LLC | 0.00% | No change | 2 | $4 |
| Huntington National Bank | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is PMCB's weight in each manager's 13F, not the share of Pharmacyte Biotech Inc. the manager owns.